Literature DB >> 8626415

Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling.

D D D'Angelo1, J J Eubank, M G Davis, G W Dorn.   

Abstract

The human platelet thromboxane A2 receptor is a member of the G-protein-coupled superfamily of receptors. Previous pharmacologic studies examining the effects of biochemical reduction, oxidation, or sulfhydryl alkylation on thromboxane receptors have suggested a role for cysteines in determining receptor binding characteristics. To characterize the roles of individual cysteines, we employed site-directed mutagenesis to substitute serines for cysteines at seven positions throughout the human K562 thromboxane receptor and analyzed mutant receptor radioligand ([1S-(1alpha,2beta(5Z),3alpha- (1E,3S),4alpha]-7-[3-(3-hydroxy-4-(p-iodophenoxy)-l-butenyl)-7-oxabicyclo-[2. 2.1]heptane-2-yl]-5-heptenoic acid) binding and calcium signaling. Replacing cysteines in the amino terminus (amino acid position 11), and transmembrane domains two and six (positions 68 and 257) had little effect on thromboxane receptor binding or signaling. Introduction of serines for cysteines in the first (position 105) or the second (position 183) extracellular loop eliminated thromboxane receptor binding, consistent with the existence of a critical disulfide bond between these positions. Mutation of a second cysteine in extracellular loop one (position 102) resulted in a receptor with decreased binding affinity and low binding capacity that transduced only a low amplitude calcium signal, suggesting the involvement of a free sulfhydryl group at this location in receptor-ligand interactions. Finally, mutation of the cysteine at position 223, located in intracellular loop three, resulted in a receptor with normal ligand binding characteristics, but which did not transduce a calcium signal. Some additional amino acid substitutions in this region of the receptor (Cys-223 --> Ala, Thr-221 --> Met) resulted in receptors that had normal binding but transduced low amplitude calcium signals, while other mutations in the same region (His-224 --> Arg and His-227 --> Arg) exhibited normal binding and calcium signaling characteristics. These findings demonstrate that cysteines in extracellular loops one and two contribute to proper ligand binding to thromboxane receptors and show the importance of discrete amino acid sequences in the third intracellular loop, especially cysteine 223, in thromboxane receptor-effector coupling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626415     DOI: 10.1074/jbc.271.11.6233

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist.

Authors:  Youyong Li; Fangqiang Zhu; Nagarajan Vaidehi; William A Goddard; Felix Sheinerman; Stephan Reiling; Isabelle Morize; Lan Mu; Keith Harris; Ali Ardati; Abdelazize Laoui
Journal:  J Am Chem Soc       Date:  2007-08-11       Impact factor: 15.419

2.  New insights into structural determinants for prostanoid thromboxane A2 receptor- and prostacyclin receptor-G protein coupling.

Authors:  Raja Chakraborty; Sai Prasad Pydi; Scott Gleim; Rajinder Pal Bhullar; John Hwa; Shyamala Dakshinamurti; Prashen Chelikani
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

3.  Analysis of adenosine A₂a receptor stability: effects of ligands and disulfide bonds.

Authors:  Michelle A O'Malley; Andrea N Naranjo; Tzvetana Lazarova; Anne S Robinson
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

4.  Role of cysteine 341 and arginine 348 of GLP-1 receptor in G-protein coupling.

Authors:  Aljosa Bavec; Yang Jiang; Ulo Langel; Matjaz Zorko
Journal:  Mol Biol Rep       Date:  2006-11-14       Impact factor: 2.316

5.  Regulation of thromboxane receptor signaling at multiple levels by oxidative stress-induced stabilization, relocation and enhanced responsiveness.

Authors:  Stephen K Ball; Mark C Field; John R Tippins
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

Review 6.  Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

Authors:  M T M van Jaarsveld; J M Houthuijzen; E E Voest
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

7.  Involvement of non-conserved residues important for PGE2 binding to the constrained EP3 eLP2 using NMR and site-directed mutagenesis.

Authors:  Annirudha Chillar; Jiaxin Wu; Shui-Ping So; Ke-He Ruan
Journal:  FEBS Lett       Date:  2008-07-22       Impact factor: 4.124

Review 8.  Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.

Authors:  Jochen Bauer; Anne Ripperger; Stefan Frantz; Süleyman Ergün; Edzard Schwedhelm; Ralf A Benndorf
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

9.  Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysis.

Authors:  Scott Gleim; Jeremiah Stitham; Wai Ho Tang; Hong Li; Karen Douville; Prashen Chelikani; Jeffrey J Rade; Kathleen A Martin; John Hwa
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  Structure modeling of all identified G protein-coupled receptors in the human genome.

Authors:  Yang Zhang; Mark E Devries; Jeffrey Skolnick
Journal:  PLoS Comput Biol       Date:  2006-02-17       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.